Creative Medical Technology Holdings, Inc. (CELZ) financial statements (2022 and earlier)

Company profile

Business Address 211 E. OSBORN RD.
PHOENIX, AZ 85012
State of Incorp. NV
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments10,7249889304142220
Cash and cash equivalents10,7249889304142220
Receivables  6105  
Inventory, net of allowances, customer advances and progress billings11      
Inventory11      
Other undisclosed current assets2      
Total current assets:10,7379894314182220
Noncurrent Assets
Intangible assets, net (including goodwill)528620437164185101 
Intangible assets, net (excluding goodwill)528620437164185101 
Other undisclosed noncurrent assets3      
Total noncurrent assets:531620437164185101 
TOTAL ASSETS:11,2687185314772033230
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities7865114413532617117
Accounts payable7623513213322386617
Accrued liabilities2416012022235 
Debt 7891,062682377  
Derivative instruments and hedges, liabilities 38,7426,8483,2271,309  
Due to related parties14111111113141
Other undisclosed current liabilities250469240198478380 
Total current liabilities:1,05040,5218,6024,4722,435454158
Noncurrent Liabilities
Long-term debt and lease obligation    1  
Long-term debt, excluding current maturities    1  
Liabilities, other than long-term debt    32626
Accounts payable and accrued liabilities    31 
Due to related parties     2526
Total noncurrent liabilities:    42626
Total liabilities:1,05040,5218,6024,4722,439480184
Stockholders' equity
Stockholders' equity attributable to parent, including:10,218(39,803)(8,071)(3,995)(2,236)(158)(184)
Common stock67692290311510518
Additional paid in capital53,87921,31617,46812,1811,075504154
Accumulated deficit(43,668)(61,890)(25,565)(17,081)(3,426)(767)(356)
Other undisclosed stockholders' equity attributable to parent 333   
Total stockholders' equity:10,218(39,803)(8,071)(3,995)(2,236)(158)(184)
TOTAL LIABILITIES AND EQUITY:11,2687185314772033230

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues881651661245  
Cost of revenue(48)(51)(45)(70)(8)  
Gross profit:4011412054(3)  
Operating expenses(3,166)(1,229)(1,250)(1,168)(1,175)(760)(21)
Other undisclosed operating loss     (6) 
Operating loss:(3,126)(1,115)(1,130)(1,114)(1,178)(766)(21)
Nonoperating income (expense)22,338(35,210)(7,354)(12,541)(1,481)  
Interest and debt expense586(1,230)(366)408(378)(6)(10)
Income (loss) from continuing operations before equity method investments, income taxes:19,797(37,555)(8,850)(13,247)(3,037)(772)(31)
Other undisclosed income (loss) from continuing operations before income taxes(586)1,230366(408)   
Net income (loss):19,212(36,325)(8,484)(13,656)(3,037)(772)(31)
Other undisclosed net income attributable to parent    3786 
Net income (loss) attributable to parent:19,212(36,325)(8,484)(13,656)(2,659)(766)(31)
Preferred stock dividends and other adjustments(197)      
Other undisclosed net income available to common stockholders, basic197      
Net income (loss) available to common stockholders, basic:19,212(36,325)(8,484)(13,656)(2,659)(766)(31)
Other undisclosed net loss available to common stockholders, diluted(989)      
Net income (loss) available to common stockholders, diluted:18,222(36,325)(8,484)(13,656)(2,659)(766)(31)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):19,212(36,325)(8,484)(13,656)(3,037)(772)(31)
Comprehensive income (loss), net of tax, attributable to parent:19,212(36,325)(8,484)(13,656)(3,037)(772)(31)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: